Uniindia: Mumbai, Nov 3 (UNI) Pharma major, Alembic Pharma on Thursday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to market Ketorolac Tromethamine Tablets USP, 10 mg.
Get latest articles and stories on Latest News at LatestLY. Dr Reddy s Laboratories on Tuesday said it along with Senores Pharmaceuticals, Inc has launched Ketorolac Tromethamine tablets, used for managing severe pain, in the US market. Latest News | Dr Reddy s Launches Pain Medication in US.
Dr Reddys Labs (RDY) and Senores Launch Ketorolac Tromethamine Tablets USP, 10 mg in the US streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.